Lipoprotein (a) level and mortality in patients with critical lower limb ischaemia

European Journal of Vascular and Endovascular Surgery

Volumn 22, Issue 2, 2001, Pages 124-129

  Cheng, S W K ^a   Ting, A C W ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Lipoprotein (a); Peripheral vascular diseases; Survival

Indexed keywords

BIOCHEMICAL MARKER; LIPOPROTEIN A;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CRITICAL ILLNESS; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; KIDNEY DISEASE; LEG AMPUTATION; LEG ARTERY; LEG ISCHEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RELIABILITY; RISK FACTOR; SURVIVAL;

EID: 0034904348     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.2001.1431     Document Type: Article

References (21)

1. Mortality over a period of 10 years in patients with peripheral arterial disease
2. Long-term mortality and its predictors in patients with critical leg ischemia
3. Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular disease
4. Lipoprotein (a) and general risk factors in patients with angiographically assessed peripheral vascular disease
5. Lipoprotein (a): A risk factor for peripheral vascular disease
6. Lipoprotein Lp(a) and peripheral vascular disease
7. Recommended standards for reports dealing with lower extremity ischemia: Revised version
8. Automated measurement of Lp(a) by immunoturbidimetric analysis
9. Lipoprotein (a) and coronary heart disease. Meta-analysis of prospective studies
10. Lipoprotein (a) in patients with acute cerebral ischemia
11. Lipoprotein (a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes
12. Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study
13. Serum Lp(a) lipoprotein concentration is not associated with clinical and angiographic outcome five years after coronary artery bypass graft surgery
14. Is apolipoprotein (a) a susceptibility gene for type I diabetes mellitus and related to long term survival?
15. Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study
16. Intermittent claudication in 8343 men and 21-year specific mortality follow-up
17. Predictors of long-term patient survival after in situ vein leg bypass
18. A 10-year follow-up of patients presenting with ischaemic rest pain of the lower limbs
19. Lipoprotein (a) and coronary thromosis and restenosis after stent placement
20. Usefulness of lipids, lipoprotein (a) and fibrinogen measurements in identifying subjects at risk of occlusive complications following vascular and endovascular surgery
21. Lipoprotein (a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease